<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Plantz MA</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>U.S. Department of Energy</funding><funding>Argonne National Laboratory</funding><funding>Office of Science</funding><funding>National Institutes of Health</funding><funding>NIAMS NIH HHS</funding><pagination>146-158</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8154748</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>127</volume><pubmed_abstract>We recently developed a recombinant growth factor-free bone regenerative scaffold composed of stoichiometric hydroxyapatite (HA) ceramic particles and human demineralized bone matrix (DBM) particles (HA-DBM). Here, we performed the first pre-clinical comparative evaluation of HA-DBM relative to the industry standard and established positive control, recombinant human bone morphogenetic protein-2 (rhBMP-2), using a rat posterolateral spinal fusion model (PLF). Female Sprague-Dawley rats underwent bilateral L4-L5 PLF with implantation of the HA-DBM scaffold or rhBMP-2. Fusion was evaluated using radiography and blinded manual palpation, while biomechanical testing quantified the segmental flexion-extension range-of-motion (ROM) and stiffness of the fused segments at 8-weeks postoperatively. </pubmed_abstract><journal>Acta biomaterialia</journal><pubmed_title>Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model.</pubmed_title><pmcid>PMC8154748</pmcid><funding_grant_id>R01 AR069580</funding_grant_id><funding_grant_id>DE-AC02-06CH11357</funding_grant_id><funding_grant_id>R01AR069580</funding_grant_id><pubmed_authors>Blank KR</pubmed_authors><pubmed_authors>Minardi S</pubmed_authors><pubmed_authors>Shah RN</pubmed_authors><pubmed_authors>Hallman M</pubmed_authors><pubmed_authors>Plantz MA</pubmed_authors><pubmed_authors>Yun C</pubmed_authors><pubmed_authors>Stock SR</pubmed_authors><pubmed_authors>Greene AC</pubmed_authors><pubmed_authors>Hsu WK</pubmed_authors><pubmed_authors>Lyons JG</pubmed_authors><pubmed_authors>Muriuki M</pubmed_authors><pubmed_authors>Jeong S</pubmed_authors><pubmed_authors>Yamaguchi JT</pubmed_authors><pubmed_authors>Havey RM</pubmed_authors><pubmed_authors>Ellenbogen DJ</pubmed_authors><pubmed_authors>Patwardhan AG</pubmed_authors><pubmed_authors>Hsu EL</pubmed_authors><pubmed_authors>Jakus AE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model.</name><description>We recently developed a recombinant growth factor-free bone regenerative scaffold composed of stoichiometric hydroxyapatite (HA) ceramic particles and human demineralized bone matrix (DBM) particles (HA-DBM). Here, we performed the first pre-clinical comparative evaluation of HA-DBM relative to the industry standard and established positive control, recombinant human bone morphogenetic protein-2 (rhBMP-2), using a rat posterolateral spinal fusion model (PLF). Female Sprague-Dawley rats underwent bilateral L4-L5 PLF with implantation of the HA-DBM scaffold or rhBMP-2. Fusion was evaluated using radiography and blinded manual palpation, while biomechanical testing quantified the segmental flexion-extension range-of-motion (ROM) and stiffness of the fused segments at 8-weeks postoperatively. </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-04T20:15:35.465Z</modification><creation>2025-04-04T20:15:35.465Z</creation></dates><accession>S-EPMC8154748</accession><cross_references><pubmed>33831576</pubmed><doi>10.1016/j.actbio.2021.03.060</doi></cross_references></HashMap>